文献速递物质与行为成瘾

妊娠对药物滥用风险的保护作用:人群、共亲属、共配偶及个体内分析

The Protective Effect of Pregnancy on Risk for Drug Abuse: A Population, Co-Relative, Co-Spouse, and Within-Individual Analysis.
PubMed 文献 · Am J Psychiatry · 2017-06-09

该研究基于瑞典1980-1990年出生、20-35岁生育的女性(N=149,512),通过前瞻性队列、共亲属、共配偶及个体内分析发现,妊娠期间药物滥用风险显著降低(未调整OR=0.67,95%CI=0.60-0.74),且共亲属和个体内分析提示该关联很大程度上是因果性的,产后近期风险也显著降低。

要点

  • 妊娠期间药物滥用风险显著低于非妊娠期(未调整OR=0.67)。
  • 共亲属和个体内分析支持妊娠对减少药物滥用的因果性保护作用。
  • 产后早期(如0-242天)药物滥用风险也显著降低(OR=0.13)。

核心结论

  • 妊娠期间女性药物滥用风险显著降低,多种分析提示该关联很大程度上是因果性的,妊娠可能是停止药物滥用的强内在动机,产后近期也有类似保护效应。

研究设计与样本

  • 前瞻性队列研究,纳入瑞典1980-1990年出生、20-35岁生育的女性共149,512人,药物滥用信息来自医疗、犯罪和药房登记系统。

主要发现

  • 人群分析中妊娠期药物滥用未调整OR=0.67(95%CI=0.60-0.74)。
  • 共亲属分析中, cousins discordant for pregnancy的OR=0.49(95%CI=0.39-0.62),siblings discordant for pregnancy的OR=0.35(95%CI=0.24-0.51)。
  • 妊娠不一致的单卵双胞胎中OR=0.17(95%CI=0.10-0.31)。
  • 个体内分析中妊娠期相比孕前等效间隔的OR=0.22(95%CI=0.19-0.26)。
  • 与同居父亲相比,母亲妊娠期药物滥用风险降低更明显(OR=0.40,95%CI=0.34-0.47)。

临床怎么用

  • 妊娠期和产后近期应重视药物滥用风险评估与干预,可借助此动机窗口开展戒断支持。
  • 对低父母教育水平及无同居吸毒父亲的患者,妊娠保护效应可能更明显,需个体化关注。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The authors sought to determine whether pregnancy is an intrinsic motivator for cessation of drug abuse. METHOD: The authors conducted prospective cohort, co-relative, co-spouse, and within-person analyses of registration for drug abuse during pregnancy among Swedish women born between 1980 and 1990 who gave birth between ages 20 and 35 (N=149,512). Drug abuse was assessed from medical, criminal, and pharmacy registries. RESULTS: In the population, rates of drug abuse were lower during pregnancy (unadjusted odds ratio=0.67, 95% CI=0.60, 0.74). Compared with population results, the negative association between pregnancy and drug abuse was moderately stronger in cousins (odds ratio=0.49, 95% CI=0.39, 0.62) and substantially stronger in siblings (odds ratio=0.35, 95% CI=0.24, 0.51) discordant for pregnancy. The estimated odds ratio for drug abuse in pregnancy-discordant monozygotic twins was even stronger, at 0.17 (95% CI=0.10, 0.31). Within individuals, the odds ratio for drug abuse while pregnant compared with an equivalent prepregnancy interval was similar to that seen in pregnancy-discordant monozygotic twins, at 0.22 (95% CI=0.19, 0.26). Compared with cohabiting fathers, mothers had a greater reduction in risk for drug abuse during pregnancy (odds ratio=0.40, 95% CI=0.34, 0.47). Pregnancy was more protective in women with low parental education and without a cohabiting, actively drug-abusing father. Compared with prepregnancy baseline, within-individual analyses indicate that risk for drug abuse is also substantially reduced in the postpartum period, for example, the odds ratio for postpartum days 0-242 was 0.13 (95% CI=0.11, 0.16). CONCLUSIONS: Risk for drug abuse in women is substantially reduced during pregnancy. Multiple analyses suggest that this association is largely causal, suggesting that pregnancy is indeed a strong intrinsic motivator for drug abuse cessation. Similar strong protective effects may be present in the immediate postpartum period. Our results have implications for our etiologic models of drug abuse and especially for contingency management programs seeking to reduce drug abuse risk.

来源:Am J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Kendler KS, Ohlsson H, Svikis DS, et al. The Protective Effect of Pregnancy on Risk for Drug Abuse: A Population, Co-Relative, Co-Spouse, and Within-Individual Analysis. Am J Psychiatry. 2017. PMID: 28595490. doi:10.1176/appi.ajp.2017.16091006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。